Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.
Jiao H, Tóth B, Erdos M, Fransson I, Rákóczi E, Balogh I, Magyarics Z, Dérfalvi B, Csorba G, Szaflarska A, Megarbane A, Akatcherian C, Dbaibo G, Rajnavölgyi E, Hammarström L, Kere J, Lefranc G, Maródi L. Jiao H, et al. Among authors: derfalvi b. Mol Immunol. 2008 Nov;46(1):202-6. doi: 10.1016/j.molimm.2008.07.001. Epub 2008 Aug 15. Mol Immunol. 2008. PMID: 18706697
Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study.
Tóth B, Volokha A, Mihas A, Pac M, Bernatowska E, Kondratenko I, Polyakov A, Erdos M, Pasic S, Bataneant M, Szaflarska A, Mironska K, Richter D, Stavrik K, Avcin T, Márton G, Nagy K, Dérfalvi B, Szolnoky M, Kalmár A, Belevtsev M, Guseva M, Rugina A, Kriván G, Timár L, Nyul Z, Mosdósi B, Kareva L, Peova S, Chernyshova L, Gherghina I, Serban M, Conley ME, Notarangelo LD, Smith CI, van Dongen J, van der Burg M, Maródi L. Tóth B, et al. Among authors: derfalvi b. Mol Immunol. 2009 Jun;46(10):2140-6. doi: 10.1016/j.molimm.2009.03.012. Epub 2009 May 5. Mol Immunol. 2009. PMID: 19419768
Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies.
Borte M, Kriván G, Derfalvi B, Maródi L, Harrer T, Jolles S, Bourgeois C, Engl W, Leibl H, McCoy B, Gelmont D, Yel L. Borte M, et al. Among authors: derfalvi b. Clin Exp Immunol. 2017 Jan;187(1):146-159. doi: 10.1111/cei.12866. Epub 2016 Oct 18. Clin Exp Immunol. 2017. PMID: 27613250 Free PMC article. Clinical Trial.
A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency.
Krivan G, Chernyshova L, Kostyuchenko L, Lange A, Nyul Z, Derfalvi B, Musial J, Bellon A, Kappler M, Sadoun A, Bernatowska E. Krivan G, et al. Among authors: derfalvi b. J Clin Immunol. 2017 Aug;37(6):539-547. doi: 10.1007/s10875-017-0416-4. Epub 2017 Jul 15. J Clin Immunol. 2017. PMID: 28711959 Free PMC article.
The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Orbán I, Constantin T, Dérfalvi B, Sevcic K, Garan D, Káposzta R, Poór G, Kiss E, Ponyi A, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). Orbán I, et al. Among authors: derfalvi b. Rheumatol Int. 2018 Apr;38(Suppl 1):243-250. doi: 10.1007/s00296-018-3955-y. Epub 2018 Apr 7. Rheumatol Int. 2018. PMID: 29637341 Free PMC article.
B cell development in chromosome 22q11.2 deletion syndrome.
Derfalvi B, Maurer K, McDonald McGinn DM, Zackai E, Meng W, Luning Prak ET, Sullivan KE. Derfalvi B, et al. Clin Immunol. 2016 Feb;163:1-9. doi: 10.1016/j.clim.2015.12.004. Epub 2015 Dec 10. Clin Immunol. 2016. PMID: 26689329
42 results